Table 4.
Preferred term | Total, n (%) (n = 298) |
---|---|
Any TEAE | 195 (65.4) |
Upper respiratory infection | 63 (21.1) |
Nasopharyngitis | 33 (11.1) |
Cough | 26 (8.7) |
Pyrexia | 25 (8.4) |
Influenza | 23 (7.7) |
Headache | 21 (7.0) |
Viral upper respiratory tract infection | 21 (7.0) |
Pharyngitis streptococcal | 19 (6.4) |
Gastroenteritis | 15 (5.0) |
Proportions are based on subject-level counts.
Abbreviation: TEAE, treatment-emergent adverse event.